{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:36:07Z","timestamp":1787160967576,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY18H120003"],"award-info":[{"award-number":["LY18H120003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.exer.2021.108446","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T03:07:28Z","timestamp":1610939248000},"page":"108446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling"],"prefix":"10.1016","volume":"204","author":[{"given":"Yimei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-2369","authenticated-orcid":false,"given":"Shengzhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108446_bib1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.exer.2021.108446_bib2","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1073\/pnas.78.12.7314","article-title":"Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits","volume":"78","author":"Antoniades","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108446_bib3","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1073\/pnas.0438014100","article-title":"Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration","volume":"100","author":"Bora","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108446_bib4","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1167\/iovs.07-1206","article-title":"The angiopoietin\/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy","volume":"49","author":"Cai","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib5","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1167\/iovs.12-10048","article-title":"Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARalpha-dependent and -independent pathways in ARPE-19 cells","volume":"53","author":"Cai","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2005.10.013","article-title":"A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib","volume":"8","author":"Chauhan","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.exer.2021.108446_bib7","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108446_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ydbio.2003.08.015","article-title":"Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival","volume":"264","author":"Darland","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.exer.2021.108446_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-6-10","article-title":"Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts","volume":"6","author":"Donovan","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.exer.2021.108446_bib10","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/IAE.0b013e3181a2c1c3","article-title":"Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration","volume":"29","author":"Forooghian","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.exer.2021.108446_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.110","article-title":"Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism","volume":"7","author":"Foxton","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exer.2021.108446_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053263","article-title":"Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib","volume":"8","author":"Gelman","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108446_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2021.108446_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.exer.2016.02.010","article-title":"Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models","volume":"145","author":"Giddabasappa","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108446_bib16","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108446_bib17","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","article-title":"Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse","volume":"126","author":"Hellstrom","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.exer.2021.108446_bib18","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1242\/dev.00721","article-title":"Roles of PDGF in animal development","volume":"130","author":"Hoch","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.exer.2021.108446_bib19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exer.2021.108446_bib20","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1038\/srep18316","article-title":"Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins 2(Akita) diabetic mouse","volume":"5","author":"Hombrebueno","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2021.108446_bib21","doi-asserted-by":"crossref","first-page":"847373","DOI":"10.1155\/2015\/847373","article-title":"Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis","volume":"2015","author":"Hsu","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2021.108446_bib22","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.0602131103","article-title":"Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration","volume":"103","author":"Imamura","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2021.108446_bib23","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1167\/iovs.07-1426","article-title":"Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin","volume":"49","author":"Izumi-Nagai","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108446_bib25","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1167\/iovs.12-11380","article-title":"The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model","volume":"54","author":"Jawad","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jnc.14214","article-title":"Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells","volume":"143","author":"Jiang","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2021.108446_bib27","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108446_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V53.6.1043.1043","article-title":"Platelet alpha granules contain a growth factor for fibroblasts","volume":"53","author":"Kaplan","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.exer.2021.108446_bib29","doi-asserted-by":"crossref","first-page":"15500","DOI":"10.1074\/jbc.M110.113787","article-title":"Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3 beta phosphorylation","volume":"285","author":"Kumar","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108446_bib30","first-page":"1929","article-title":"Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor","volume":"37","author":"Kvanta","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10495-006-4689-y","article-title":"JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL\/caspase-8 and mitochondria-dependent pathways","volume":"11","author":"Lauricella","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.exer.2021.108446_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2019.01.009","article-title":"Secretogranin III as a novel target for the therapy of choroidal neovascularization","volume":"181","author":"LeBlanc","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108446_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1471-4159.2004.02813.x","article-title":"A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury","volume":"91","author":"Lee","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2021.108446_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/sj.onc.1206223","article-title":"PDGF-D is a potent transforming and angiogenic growth factor","volume":"22","author":"Li","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2021.108446_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IAE.0b013e3182657fff","article-title":"Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy","volume":"33","author":"Lois","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.exer.2021.108446_bib36","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2005-03-1173","article-title":"Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma","volume":"106","author":"Lonial","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exer.2021.108446_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.2536956","article-title":"Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes","volume":"243","author":"Matsui","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.exer.2021.108446_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108446_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exer.2021.108446_bib40","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/DDDT.S219350","article-title":"Comparing the efficacy of an anti-human VEGF-A neutralizing antibody versus bevacizumab on A laser-induced choroidal neovascularization (CNV) rhesus monkey model","volume":"13","author":"Olvera-Montano","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exer.2021.108446_bib41","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajpath.2014.02.016","article-title":"Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model","volume":"184","author":"Park","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108446_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","article-title":"Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab","volume":"143","author":"Peters","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108446_bib43","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1167\/iovs.14-15067","article-title":"Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation","volume":"55","author":"Poor","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1","volume":"145","author":"Regillo","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108446_bib45","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2021.108446_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/0008-5472.CAN-05-1195","article-title":"Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells","volume":"66","author":"Roccaro","year":"2006","journal-title":"Can. Res."},{"key":"10.1016\/j.exer.2021.108446_bib47","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108446_bib48","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2021.108446_bib49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ophtha.2017.12.026","article-title":"Macular atrophy in the HARBOR study for neovascular age-related macular degeneration","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108446_bib50","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archopht.123.6.774","article-title":"Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108446_bib52","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.ajpath.2016.02.018","article-title":"Targeting platelet-derived growth factor receptor beta(+) scaffold formation inhibits choroidal neovascularization","volume":"186","author":"Strittmatter","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108446_bib53","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1349-7006.2010.01544.x","article-title":"Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2\/M transition","volume":"101","author":"Tamura","year":"2010","journal-title":"Canc. Sci."},{"key":"10.1016\/j.exer.2021.108446_bib54","article-title":"Proteasome inhibitors activate autophagy involving inhibition of PI3K-Akt-mTOR pathway as an anti-oxidation defense in human RPE cells","volume":"9","author":"Tang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108446_bib55","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1172\/JCI129862","article-title":"Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better","volume":"129","author":"Usui-Ouchi","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2021.108446_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nm1524","article-title":"Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia","volume":"13","author":"Vilimas","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2021.108446_bib57","first-page":"263","article-title":"Pegaptanib in the treatment of wet, age-related macular degeneration","volume":"1","author":"Vinores","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exer.2021.108446_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108446_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.exer.2019.03.018","article-title":"Intravenous injection of l-aspartic acid beta-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation","volume":"182","author":"Wu","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108446_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3928\/23258160-20150304-01","article-title":"Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T","volume":"46","author":"Wykoff","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.exer.2021.108446_bib61","first-page":"37","article-title":"Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys","volume":"14","author":"Zhang","year":"2008","journal-title":"Mol. Vis."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:29:44Z","timestamp":1762147784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0014483521000117"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108446","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108446"}}